Abstract
cytomegalovirus (cmv) infection is an important cause of morbidity and mortality after allogeneic transplant. interstitial pneumonia (ip) is the most common manifestation of cmv in bmt patients, with a 30–48% mortality rate despite adequate treatment. most cmv infection occurs in the first 100 days. however, prolonged ganciclovir (gcv) prophylaxis has favored the occurrence of late cmv ip, probably by inhibition of the development of cmv-specific t cell lymphocyte responses. we report the case of a patient treated with an allogeneic bmt who received pre-emptive gcv until day +100 because of cmv-positive antigenemia. he developed a cmv ip on day +811 post bmt, which responded to treatment. we intend to alert clinicians that even at long-term (>1 year) post-BMT, CMV is a possible cause of IP in high-risk patients. Bone Marrow Transplantation (2000) 26, 443–444.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis 1986 153: 478–488
Enright H, Haake R, Weisdorf D et al. Cytomegalovirus pneumonia after bone marrow transplantation Transplantation 1993 55: 1339–1346
Nguyen K, Champlin R, Giralt S et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients Clin Infect Dis 1999 28: 618–623
Li CR, Greemberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis Blood 1994 83: 1971–1979
Boeckh M, Gooley TA, Myerson D et al. Cytomegalovirus pp65 antigenemia – guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study Blood 1996 88: 4063–4071
Cathomas G, Morris P, Pekle K et al. Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture and the direct immunostaining of alveolar cells Blood 1993 81: 1909–1914
Sttochi R, Ward KN, Fanin R et al. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation Haematologica 1999 84: 71–79
Reddy V, Hao H, Lipton J et al. Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy J Clin Virol 1999 13: 149–159
Riddell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunedificient humans by adoptive transfer of T-cell clones Science 1992 257: 238–241
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Medeiros, C., Moreira, V. & Pasquini, R. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation. Bone Marrow Transplant 26, 443–444 (2000). https://doi.org/10.1038/sj.bmt.1702538
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702538
Keywords
This article is cited by
-
Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match
Genes & Immunity (2002)